Door:
Omegaplan
Forum:
Oxurion (vh ThromboGenics)
Net binnen. Topline data Fase 1 zijn top.Leuven, Belgium, 9 February 2020 – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation therapies designed to treat patients with diabe...